fbpx

Monthly Archives: January 2013

Google Earnings, Q4 FY’12

By |2013-01-24T18:30:23-05:00January 24th, 2013|Markets|

The main take away from this quarter's earnings release is the following: Torrid top line growth. 32.5 yoy% 24.8 5yr CAGR% But, the growth has been expensive, lower margins (25.43% down from 32.22%): Therefore, bottom line growth has slowed. 10.8 yoy% 20.7 5yr CAGR%   Google makes the majority of their money as an advertiser.  In order to drive this [...]

IBM Earnings, Q4 & FY 2012

By |2013-01-24T12:17:26-05:00January 24th, 2013|Markets|

Some good results from Big Blue in an extremely tough environment. Across the board there was strength in the key areas, including 80% growth in cloud computing (a segment we want to see IBM as a leader). In terms of numbers, EPS growth was 10% for the full year, to $14.37, while net profits rose 5% (the difference is the [...]

Celgene

By |2013-01-24T08:11:07-05:00January 24th, 2013|Stocks|

Celgene, part of our Global Opportunities portfolio, reported earnings this morning slightly better than expected, although it appears revenue was a slight miss: Celgene Corporation (CELG) reported net product sales of $1,416 million for the fourth quarter 2012, a 14 percent increase from the same period in 2011. Adjusted net income for the fourth quarter 2012 increased 21 percent to [...]

Amerisource Bergen Earnings

By |2013-01-24T08:06:51-05:00January 24th, 2013|Markets, Stocks|

Amerisource Bergen, part of our Global Opportunities portfolio, reported earnings this morning of $0.69/share, a couple of pennies better than expected. AmerisourceBergen Corporation (ABC) today reported that in its fiscal year 2013 first quarter, ended December 31, 2012, diluted earnings per share from continuing operations were $0.69, a 13 percent increase. Revenue in the quarter was $21.5 billion, up 6 [...]

Amgen Earnings

By |2013-01-23T17:53:50-05:00January 23rd, 2013|Markets, Stocks|

Amgen reported earnings after the close that were better than expected (via Bloomberg): Amgen Inc. (AMGN), the world’s largest biotechnology company, reported fourth-quarter profit that beat analyst estimates as sales of arthritis and bone drugs rose. Net income declined 16 percent to $788 million, or $1.01 a share, from $934 million, or $1.08 a share, a year earlier, on higher [...]

Apple Earnings

By |2013-01-23T17:46:37-05:00January 23rd, 2013|Markets, Stocks|

Apple reported earnings after the close. It appears they beat on the bottom line but missed on revenue (via MarketWatch): Apple Inc. posted flat earnings for its first fiscal quarter on Wednesday afternoon, slightly beating Wall Street’s expectations despite a revenue line that was a little weaker than expected. Apple is part of our Global Opportunities portfolio (and has been [...]

Unilever Sales Update

By |2013-01-23T10:12:26-05:00January 23rd, 2013|Markets, Stocks|

Unilever provided an update today (via Yahoo): Unilever PLC, the maker of consumer products such as Dove soaps and Magnum ice cream, says sales rose 7.8 percent to €12.6 billion ($16.8 billion) in the fourth quarter thanks to strong demand in developing economies, the company's biggest market in 2012. Along with the fourth-quarter figures, the company reported full-year net profit [...]

Abbott Labs Earnings

By |2013-01-23T10:09:07-05:00January 23rd, 2013|Markets, Stocks|

Abbott Labs reported earnings this morning that were slightly better than expected and raised guidance slightly for next year (via Reuters): Abbott Laboratories Inc, which spun off its branded prescription drugs business earlier this month, on Wednesday forecast 2013 earnings above Wall Street expectations. Abbott said it expects earnings for the full year, excluding special items, of $1.98 to $2.04 per share. Analysts, on average, have forecast $1.95, [...]

IBM Earnings

By |2013-01-22T16:37:34-05:00January 22nd, 2013|Markets, Stocks|

IBM, a part of our Global Opportunities portfolio, reported earnings after the bell. Revenue, earnings and guidance were all better than expected. Via Business Insider: The company reported earnings of $5.39 per share versus estimates of $5.25. The company also beat expectations on revenues, reporting sales of $29.3 billion. Finally, IBM issued guidance for full-year 2013 earnings of $16.70 per [...]

Google Earnings

By |2013-01-22T16:33:00-05:00January 22nd, 2013|Markets, Stocks|

Google, part of our Global Opportunities portfolio,  reported earnings after the close today. It looks like revenue was a little below expectations while the bottom line beat. The stock is up about $30 in after hours trading. Highlights from Barron's: Revenue in the three months ended in December rose 36%, year over year, to $11.34 billion, excluding the cost of [...]

Go to Top